
The currently available anti-leishmanial antimonial drugs, together with other antimony compounds were individually tested, in combination with difluoromethylornithine (DFMO), against experimental murine trypanosomiasis with central nervous system involvement. Satisfactory cure rates could be achieved using a combination treatment of DFMO with most of these anti-leishmanial drugs, but in general, only when they were administered at least twice daily. Of the compounds tested, the most effective was antimony dimercaptosuccinate (Astiban).
Antimony, Eflornithine, Meglumine Antimoniate, Trypanosoma brucei brucei, Drug Synergism, Trypanocidal Agents, Mice, Meglumine, Trypanosomiasis, African, Antimony Sodium Gluconate, Organometallic Compounds, Animals, Drug Therapy, Combination, Female, Succimer, Tartrates
Antimony, Eflornithine, Meglumine Antimoniate, Trypanosoma brucei brucei, Drug Synergism, Trypanocidal Agents, Mice, Meglumine, Trypanosomiasis, African, Antimony Sodium Gluconate, Organometallic Compounds, Animals, Drug Therapy, Combination, Female, Succimer, Tartrates
| citations The total number of citations received by all articles of the researcher of interest. | 5 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
